Pfizer to buy Anacor for $4.5 billion
May 16, 2016 at 07:32 AM EDT
Pfizer agrees to buy Anacor in a deal valued at $5.2 billion including debt, with the per-share bid of $99.25 representing a 55% premium to Friday’s closing price.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.